Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions
| Autor: | Salvador, J., Urtasun, J. A., Duart, F. J. B., García-Campelo, R., Carbonero, R. G., Lianes, P., Llombart, A., Casado, D. I., Piera, J. M., Mateu, M. M., Puente, J., Rivera, F., Rodríguez, C. A., Virizuela, J. A., Martín, M., Garrido, P. |
|---|---|
| Přispěvatelé: | Sociedad Española de Oncología Médica |
| Rok vydání: | 2017 |
| Předmět: |
Cancer Research
Inequities General Medicine Medical Oncology Health Services Accessibility 03 medical and health sciences 0302 clinical medicine Oncology Spain 030220 oncology & carcinogenesis Neoplasms Surveys and Questionnaires Antineoplastic agents Humans 030212 general & internal medicine Erratum Healthcare Disparities Heterogeneity Societies Medical Barriers Research Article |
| Zdroj: | CLINICAL & TRANSLATIONAL ONCOLOGY r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe instname Digital.CSIC. Repositorio Institucional del CSIC Clinical & Translational Oncology Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid Consejería de Sanidad de la Comunidad de Madrid |
| ISSN: | 1699-048X |
| Popis: | [Purpose] The Spanish Society of Medical Oncology (SEOM) has conducted a study on the access to oncologic drugs across the 17 Spanish Regions with the aim of identifying potential heterogeneities and making proposals for eliminating the barriers identified at the different levels. [Methods] An Expert Panel made up of medical oncologists designed a survey on certain indications approved for 11 drugs in the approach of breast cancer, melanoma, lung cancer, prostate cancer and support treatment. This survey was sent to 144 National Health System (NHS) hospitals. [Results] 77 hospitals answered the survey. The information modules analysed were: scope of the Commission that establishes binding decisions related to drug access; conditions, stages and periods of drug application, approval and administration processes; barriers to accessing drugs. [Conclusions] The study shows variability in drug access. The SEOM makes proposals addressed to reducing the differences identified and homogenizing drug access conditions. This study was funded by SEOM. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink